Epidemiology of malignant melanoma

Skin Cancer - A World-Wide Perspective

Volumn , Issue , 2011, Pages 13-26

  Whiteman, David ^a   Green, Adele ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891434041     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-05072-5_2     Document Type: Chapter

References (144)

1. Ries, L.A.G., Eisner, M.P., Kosary, C.L., Hankey, B.F., Miller, B.A., Clegg, L., et al.: SEER Cancer Statistics Review, 1973-1997. National Cancer Institute, Bethesda (2000)
2. Fraumeni Jr., J.F.: Genes and the Environment in Cancer Causation. National Cancer Institute, Washington (2007)
3. Lancaster, H.O.: Some geographical aspects of the mortality from melanoma in Europeans. Med. J. Aust. 1, 1082-1087 (1956)
4. Lancaster, H.O., Nelson, J.: Sunlight as a cause of melanoma: a clinical survey. Med. J. Aust. 1, 452-456 (1957)
5. Deapen, D., Bernstein, L., Liu, L., Kerford, D., Balcius, P., Morrell, D., et al.: Cancer incidence in Los Angeles county. In: Curado, M.P., Edwards, B., Shin, H.R., Storm, H., Ferlay, J., Heanue, M. (eds.) Cancer Incidence in Five Continents, vol. IX. IARC Scientific, Lyon (2007)
6. Ministry of Health: Cancer in New Zealand: Trends and Projections. Ministry of Health, Wellington (2002)
7. Australian Institute of Health and Welfare (AIHW). ACIM (Australian Cancer Incidence and Mortality) Books. AIHW. Canberra (2010)
8. Crombie, I.K.: Variation of melanoma incidence with latitude in North America and Europe. Br. J. Cancer 40, 774-781 (1979)
9. Bulliard, J.L., Cox, B., Elwood, J.M.: Latitude gradients in melanoma incidence and mortality in the non-Maori population of New Zealand. Cancer Causes Control 5, 234-240 (1994)
10. Magnus, K.: Incidence of malignant melanoma of the skin in Norway, 1955-1970: Variations in time and space and solar radiation. Cancer 32, 1275-1286 (1973)
11. Armstrong, B.K.: Epidemiology of malignant melanoma: intermittent or total accumulated exposure to the sun. J. Dermatol. Surg. Oncol. 14, 835-849 (1988)
12. Coory, M., Baade, P., Aitken, J., Smithers, M., McLeod, G.R., Ring, I.: Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002. Cancer Causes Control 17(1), 21-27 (2006)
13. Marrett, L.D., Nguyen, H.L., Armstrong, B.K.: Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996. Int. J. Cancer 92(3), 457-462 (2001)
14. Jemal, A., devesa, S.S., Fears, T.R., Hartge, P., Tucker, M.A.: Recent trends in cutaneous melanoma incidence among whites in the United States. J. Natl. Cancer Inst. 93, 678-683 (2001)
15. Ulmer, M.J., Tonita, J.M., Hull, P.R.: Trends in invasive cutaneous melanoma in Saskatchewan 1970-1999. J. Cutan. Med. Surg. 7(6), 433-442 (2003)
16. MacKie, R.M., Bray, C.A., Hole, D.J.: Incidence and survival from malignant melanoma in Scotland. Lancet 360, 587-591 (2002)
17. Lasithiotakis, K.G., Leiter, U., Gorkievicz, R., Eigentler, T., Breuninger, H., Metzler, G., et al.: The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003. Cancer 107(6), 1331-1339 (2006)
18. Stang, A., Pukkala, E., Sankila, R., Soderman, B., Hakulinen, T.: Time trend analysis of the skin melanoma incidence of Finland from 1953 through 2003 including 16,414 cases. Int. J. Cancer 119(2), 380-384 (2006)
19. Lipsker, D., Engel, F., Cribier, B., Velten, M., Hedelin, G.: Trends in melanoma epidemiology suggest three different types of melanoma. Br. J. Dermatol. 157(2), 338-343 (2007)
20. de Vries, E., Bray, F.I., Coebergh, J.W., Parkin, D.M.: Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int. J. Cancer 107(1), 119-126 (2003)
21. Whiteman, D.C., Bray, C.A., Siskind, V., Green, A.C., Hole, D.J., Mackie, R.M.: Changes in the incidence of cutaneous melanoma in the west of Scotland and Queensland, Australia: hope for health promotion? Eur. J. Cancer Prev. 17(3), 243-250 (2008)
22. Garbe, C., McLeod, G.R., Buettner, P.G.: Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer 89(6), 1269-1278 (2000)
23. Welch, H.G., Woloshin, S., Schwartz, L.M.: Skin biopsy rates and incidence of melanoma: population based ecological study. Br. Med. J. 331(7515), 481 (2005)
24. Burton, R.C., Coates, M.S., Hersey, P., Roberts, G., Chetty, M.P., Chen, S., et al.: An analysis of a melanoma epidemic. Int. J. Cancer 55, 765-776 (1993)
25. Burton, R.C., Armstrong, B.K.: Recent incidence trends imply a nonmetastasizing form of invasive melanoma. Melanoma Res. 4(2), 107-113 (1994)
26. Jemal, A., Devesa, S.S., Fears, T.R., Hartge, P.: Cancer surveillance series: changing patterns of cutaneous malignant melanoma mortality rates among whites in the United States. J. Natl. Cancer Inst. 92(10), 811-818 (2000)
27. de Vries, E., Bray, F.I., Eggermont, A.M., Coebergh, J.W.: Monitoring stage-specific trends in melanoma incidence across Europe reveals the need for more complete information on diagnostic characteristics. Eur. J. Cancer Prev. 13(5), 387-395 (2004)
28. de Vries, E., Coebergh, J.W.: Cutaneous malignant melanoma in Europe. Eur. J. Cancer 40(16), 2355-2366 (2004)
29. Giles, G.G., Armstrong, B.K., Burton, R.C., Staples, M.J., Thursfield, V.J.: Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994. Br. Med. J. 312, 1121-1125 (1996)
30. Baade, P., Coory, M.: Trends in melanoma mortality in Australia: 1950-2002 and their implications for melanoma control. Aust. N. Z. J. Public Health 29(4), 383-386 (2005)
31. Lachiewicz, A.M., Berwick, M., Wiggins, C.L., Thomas, N.E.: Epidemiologic support for melanoma heterogeneity using the surveillance, epidemiology, and end results program. J. Invest. Dermatol. 128(5), 1340-1342 (2008)
32. Stang, A., Stabenow, R., Eisinger, B., Jockel, K.H.: Site-And gender-specific time trend analyses of the incidence of skin melanomas in the former German Democratic Republic (GDR) including 19351 cases. Eur. J. Cancer 39(11), 1610-1618 (2003)
33. Elwood, J.M., Gallagher, R.P.: Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure. Int. J. Cancer 78, 276-280 (1998)
34. Bulliard, J.-L.: Site-specific risk of cutaneous malignant melanoma and pattern of sun exposure in New Zealand. Int. J. Cancer 85, 627-632 (2000)
35. Perez-Gomez, B., Aragones, N., Gustavsson, P., Lope, V., Lopez-Abente, G., Pollan, M.: Do sex and site matter? Different age distribution in melanoma of the trunk among Swedish men and women. Br. J. Dermatol. 158(4), 766-772 (2008)
36. MacKie, R., Hunter, J.A., Aitchison, T.C., Hole, D., McLaren, K., Rankin, R.: Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group. Lancet 339, 971-975 (1992)
37. Bulliard, J.L., Cox, B.: Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969-1993. Int. J. Epidemiol. 29(3), 416-423 (2000)
38. Osterlind, A., Hou-Jensen, K., Moller-Jensen, O.: Incidence of cutaneous malignant melanoma in Denmark 1978-1982. Anatomic site distribution, histologic types and comparison with non-melanoma skin cancer. Br. J. Cancer 58, 385-391 (1988)
39. Magnus, K.: Habits of sun exposure and risk of malignant melanoma: an analysis of incidence rates in Norway 1955-1977 by cohort, sex, age and primary tumor site. Cancer 48, 2329-2335 (1981)
40. Popescu, N.A., Beard, C.M., Treacy, P.J., Winkelmann, R.K., O'Brien, P.C., Kurland, L.T.: Cutaneous malignant melanoma in Rochester, Minnesota: trends in incidence and survivorship, 1950 through 1985. Mayo Clin. Proc. 65, 1293-1302 (1990)
41. Masback, A., Westerdahl, J., Ingvar, C., Olsson, H., Jonsson, N.: Cutaneous malignant melanoma in South Sweden 1965, 1975, and 1985. A histopathologic review. Cancer 73, 1625-1630 (1994)
42. Green, A., MacLennan, R., Youl, P., Martin, N.: Site distribution of cutaneous melanoma in Queensland. Int. J. Cancer 53, 232-236 (1993)
43. Chen, Y.T., Zheng, T., Holford, T.R., Berwick, M., Dubrow, R.: Malignant melanoma incidence in Connecticut (United States): time trends and age-period-cohort modeling by anatomic site. Cancer Causes Control 5, 341-350 (1994)
44. Armstrong, B.K., Kricker, A.: How much melanoma is caused by sun exposure? Melanoma Res. 3, 395-401 (1993)
45. Whiteman, D.C., Whiteman, C.A., Green, A.C.: Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 12, 69-82 (2001)
46. Kraemer, K.H., Lee, M.M., Andrews, A.D., Lambert, W.C.: The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch. Dermatol. 130, 1018-1021 (1994)
47. Green, A.C., O'Rourke, M.G.E.: Cutaneous malignant melanoma in association with other skin cancers. J. Natl. Cancer Inst. 74, 977-980 (1985)
48. Levi, F., Randimbison, L., La-Vecchia, C., Erler, G., Te, V.C.: Incidence of invasive cancers following squamous cell skin cancer. Am. J. Epidemiol. 146(9), 734-739 (1997)
49. Bliss, J.M., Ford, D., Swerdlow, A.J., Armstrong, B.K., Cristofolini, M., Elwood, J.M., et al.: Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: systematic overview of 10 case-control studies. Int. J. Cancer 62, 367-376 (1995)
50. Noonan FP, Recio JA, Takayama H, et al. Neonatal sunburn and melanoma in mice. Nature. Sep 20 2001;413(6853):271-272.
51. Tucker, M.A.: Is sunlight important to melanoma causation? Cancer Epidemiol. Biomarkers Prev. 17(3), 467-468 (2008)
52. Shuster, S.: Is sun exposure a major cause of melanoma? No. Br. Med. J. 337, a764 (2008)
53. Elwood, J.M., Jopson, J.: Melanoma and sun exposure: an overview of published studies. Int. J. Cancer 73(2), 198-203 (1997)
54. Whiteman, D.C., Bray, C.A., Siskind, V., Hole, D., MacKie, R.M., Green, A.C.: A comparison of the anatomic distribution of cutaneous melanoma in two populations with different levels of sunlight: the west of Scotland and Queensland, Australia 1982-2001. Cancer Causes Control 18(5), 485-491 (2007)
55. Cooke, K.R., Fraser, J.: Migration and death from malignant melanoma. Int. J. Cancer 36(2), 175-178 (1985)
56. Khlat, M., Vail, A., Parkin, M., Green, A.: Mortality from melanoma immigrants to Australia: variation by age at arrival and duration of stay. Am. J. Epidemiol. 135, 1103-1113 (1992)
57. Wynder, E.L., Stellman, S.D.: The "over-exposed" control group. Am. J. Epidemiol. 135, 459-461 (1992)
58. Autier, P., Dore, J.F.: Influence of sun exposures during childhood and during adulthood on melanoma risk. EPIMEL and EORTC Melanoma Cooperative Group. European Organisation for Research and Treatment of Cancer. Int. J. Cancer 77(4), 533-537 (1998)
59. Dobson, A.J., Leeder, S.R.: Mortality from malignant melanoma in Australia: effects due to country of birth. Int. J. Epidemiol. 11(3), 207-211 (1982)
60. Elwood, J.M., Gallagher, R.P., Hill, G.B., Pearson, J.C.: Cutaneous melanoma in relation to intermittent and constant sun exposure-The Western Canada Melanoma Study. Int. J. Cancer 35, 427-433 (1985)
61. Osterlind, A., Tucker, M.A., Stone, B.J., Jensen, O.M.: The Danish case-control study of cutaneous malignant melanoma. II. Importance of UV-light exposure. Int. J. Cancer 42, 319-324 (1988)
62. Nelemans, P.J., Rampen, F.H.J., Ruiter, D.J., Verbeek, A.L.M.: An addition to the controversy on sunlight exposure and melanoma risk: a meta-Analytical approach. J. Clin. Epidemiol. 48, 1331-1342 (1995)
63. Gandini, S., Sera, F., Cattaruzza, M.S., Pasquini, P., Picconi, O., Boyle, P., et al.: Meta-Analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur. J. Cancer 41(1), 45-60 (2005)
64. Whiteman, D.C., Stickley, M., Watt, P., Hughes, M.C., Davis, M.B., Green, A.C.: Anatomic site, sun exposure, and risk of cutaneous melanoma. J. Clin. Oncol. 24(19), 3172-3177 (2006)
65. Rivers, J.K.: Is there more than one road to melanoma? Lancet 363(9410), 728-730 (2004)
66. Maldonado, J.L., Fridlyand, J., Patel, H., Jain, A.N., Busam, K., Kageshita, T., et al.: Determinants of BRAF mutations in primary melanomas. J. Natl. Cancer Inst. 95(24), 1878-1890 (2003)
67. Curtin, J.A., Fridlyand, J., Kageshita, T., Patel, H.N., Busam, K.J., Kutzner, H., et al.: Distinct sets of genetic alterations in melanoma. N. Engl. J. Med. 353(20), 2135-2147 (2005)
68. Gallagher, R.: Sunbeds-do they increase risk of melanoma or not? Eur. J. Cancer 41(14), 2038-2039 (2005)
69. Gallagher, R.P., Spinelli, J.J., Lee, T.K.: Tanning beds, sunlamps, and risk of cutaneous malignant melanoma. Cancer Epidemiol. Biomarkers Prev. 14(3), 562-566 (2005)
70. IARC Working Group on Risk of Skin Cancer and Exposure to Artificial Ultraviolet Light: Exposure to Artificial UV Radiation and Skin Cancer. International Agency for Research on Cancer, Lyon (2005)
71. Gandini, S., Sera, F., Cattaruzza, M.S., Pasquini, P., Abeni, D., Boyle, P., et al.: Meta-Analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur. J. Cancer 41(1), 28-44 (2005)
72. Ford, D., Bliss, J.M., Swerdlow, A.J., et al.: Risk of cutaneous melanoma associated with a family history of the disease. Int. J. Cancer 62, 377-381 (1995)
73. Petty, E.M., Gibson, L.H., Fountain, J.W., Bolognia, J.L., Yang-Feng, T.L., Housman, D.E., et al.: Molecular definition of a chromosome 9p21 germ-line deletion in a woman with multiple melanomas and a plexiform neurofibroma: implications for 9p tumor-suppressor gene(s). Am. J. Hum. Genet. 53(1), 96-104 (1993)
74. Cannon-Albright, L.A., Goldgar, D.E., Meyer, L.J., et al.: Assignment of a locus for familial melanoma,MLM, to chromosome 9p13-p22. Science 258, 1148-1152 (1992)
75. Nancarrow, D.J., Mann, G.J., Holland, E.A., et al.: Confirmation of chromosome 9p linkage in familial melanoma. Am. J. Hum. Genet. 53, 936-942 (1993)
76. Gruis, N.A., van der Velden, P.A., Sandkuijl, L.A., et al.: Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat. Genet. 10, 351-353 (1995)
77. Harland, M., Meloni, R., Gruis, N., Pinney, E., Brookes, S., Spurr, N.K., et al.: Germline mutations of the CDKN2 gene in UK melanoma families. Hum. Mol. Genet. 6(12), 2061-2067 (1997)
78. Hussussian, C., Struewing, J.P., Goldstein, A.M., et al.: Germline p16 mutations in familial melanoma. Nat. Genet. 8, 15-21 (1994)
79. Peters, G.: Tumor suppression for ARFicionados: the relative contributions of p16INK4a and p14ARF in melanoma. J. Natl. Cancer Inst. 100(11), 757-759 (2008)
80. Zuo, L., Weger, J., Yang, Q., Goldstein, A.M., Tucker, M.A., Walker, G.J., et al.: Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat. Genet. 12(1), 97-99 (1996)
81. Begg, C.B., Orlow, I., Hummer, A.J., Armstrong, B.K., Kricker, A., Marrett, L.D., et al.: Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J. Natl. Cancer Inst. 97(20), 1507-1515 (2005)
82. Goldstein, A.M., Stacey, S.N., Olafsson, J.H., Jonsson, G.F., Helgason, A., Sulem, P., et al.: CDKN2A mutations and melanoma risk in the Icelandic population. J. Med. Genet. 45(5), 284-289 (2008)
83. Bishop, D.T., Demenais, F., Goldstein, A.M., Bergman, W., Bishop, J.N., Paillerets Bressac-de, B., et al.: Geographical variation in the penetrance of CDKN2A mutations for melanoma. J. Natl. Cancer Inst. 94(12), 894-903 (2002)
84. Aitken, J., Welch, J., Duffy, D., Milligan, A., Green, A., Martin, N., et al.: CDKN2A variants in a population-based sample of Queensland families with melanoma. J. Natl. Cancer Inst. 91(5), 446-452 (1999)
85. Ung-Juurlink, C.: American Academy of Dermatology 1999 Awards for Young Investigators in Dermatology. The prevalence of CDKN2A in patients with atypical nevi and malignant melanoma. J. Am. Acad. Dermatol. 41(3), 461-462 (1999)
86. Kraemer, K.H.: Sunlight and skin cancer: another link revealed. Proc. Natl. Acad. Sci. U S A 94(1), 11-14 (1997)
87. Boni, R., Vortmeyer, A.O., Burg, G., Hofbauer, G., Zhuang, Z.: The PTEN tumour suppressor gene and malignant melanoma. Melanoma Res. 8(4), 300-302 (1998)
88. Chhajlani, V., Wikberg, J.E.: Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 309(3), 417-420 (1992)
89. Valverde, P., Healy, E., Jackson, I., Rees, J.L., Thody, A.J.: Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat. Genet. 11, 328-330 (1995)
90. Smith, R., Healy, E., Siddiqui, S., Flanagan, N., Steijlen, P.M., Rosdahl, I., et al.: Melanocortin 1 receptor variants in an Irish population. J. Invest. Dermatol. 111(1), 119-122 (1998)
91. Box, N.F., Wyeth, J.R., O'Gorman, L.E., Martin, N.G., Sturm, R.A.: Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. Hum. Mol. Genet. 6(11), 1891-1897 (1997)
92. Wong, T.H., Rees, J.L.: The relation between melanocortin 1 receptor (MC1R) variation and the generation of phenotypic diversity in the cutaneous response to ultraviolet radiation. Peptides 26(10), 1965-1971 (2005)
93. Stratigos, A.J., Dimisianos, G., Nikolaou, V., Poulou, M., Sypsa, V., Stefanaki, I., et al.: Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population. J. Invest. Dermatol. 126(8), 1842-1849 (2006)
94. Raimondi, S., Sera, F., Gandini, S., Iodice, S., Caini, S., Maisonneuve, P., et al.: MC1R variants, melanoma and red hair color phenotype: a meta-Analysis. Int. J. Cancer 122(12), 2753-2760 (2008)
95. Dwyer, T., Stankovich, J.M., Blizzard, L., FitzGerald, L.M., Dickinson, J.L., Reilly, A., et al.: Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype? Am. J. Epidemiol. 159(9), 826-833 (2004)
96. Zhang, D., Chen, C., Fu, X., Gu, S., Mao, Y., Xie, Y., et al.: A meta-Analysis of DNA repair gene XPC polymorphisms and cancer risk. J. Hum. Genet. 53(1), 18-33 (2008)
97. Blankenburg, S., Konig, I.R., Moessner, R., Laspe, P., Thoms, K.M., Krueger, U., et al.: Assessment of 3 xeroderma pigmento-sum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study. Carcinogenesis 26(6), 1085-1090 (2005)
98. Blankenburg, S., Konig, I.R., Moessner, R., Laspe, P., Thoms, K.M., Krueger, U., et al.: No association between three xeroderma pigmentosum group C and one group G gene polymorphisms and risk of cutaneous melanoma. Eur. J. Hum. Genet. 13(2), 253-255 (2005)
99. Millikan, R.C., Hummer, A., Begg, C., Player, J., de Cotret, A.R., Winkel, S., et al.: Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study. Carcinogenesis 27(3), 610-618 (2006)
100. Han, J., Colditz, G.A., Liu, J.S., Hunter, D.J.: Genetic variation in XPD, sun exposure, and risk of skin cancer. Cancer Epidemiol. Biomarkers Prev. 14(6), 1539-1544 (2005)
101. Baccarelli, A., Calista, D., Minghetti, P., Marinelli, B., Albetti, B., Tseng, T., et al.: XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk. Br. J. Cancer 90(2), 497-502 (2004)
102. Debniak, T., Scott, R.J., Gorski, B., Cybulski, C., van de Wetering, T., Serrano-Fernandez, P., et al.: Common variants of DNA repair genes and malignant melanoma. Eur. J. Cancer 44(1), 110-114 (2008)
103. Li, C., Liu, Z., Wang, L.E., Gershenwald, J.E., Lee, J.E., Prieto, V.G., et al.: Haplotype and genotypes of the VDR gene and cutaneousmelanoma risk in non-Hispanic whites in Texas: a case-control study. Int. J. Cancer 122(9), 2077-2084 (2008)
104. Houghton, A., Flannery, J., Viola, M.V.: Malignant melanoma in Connecticut and Denmark. Int. J. Cancer 25(1), 95-104 (1980)
105. Weinstock, M.A., Colditz, G.A., Willett, W.C., Stampfer, M.J., Bronstein, B.R., Mihm, M.C., et al.: Moles and site-specific cutaneous malignant melanoma in women. J. Natl. Cancer Inst. 81, 948-952 (1989)
106. Kruger, S., Garbe, C., Buttner, P., Stadler, R., Guggenmoos-Holzmann, I., Orfanos, C.E.: Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. J. Am. Acad. Dermatol. 26, 920-926 (1992)
107. Rieger, E., Soyer, H.P., Garbe, C., et al.: Overall and site-specific risk of malignant melanoma associated with nevus counts at different body sites: a multicenter case-control study of the German central malignant-melanoma registry. Int. J. Cancer 62, 393-397 (1995)
108. Chen, Y.T., Dubrow, R., Holford, T.R., Zheng, T., Barnhill, R.L., Fine, J., et al.: Malignant melanoma risk factors by anatomic site: a case-control study and polychotomous logistic regression analysis. Int. J. Cancer 67(5), 636-643 (1996)
109. Bataille, V., Sasieni, P., Grulich, A., Swerdlow, A., McCarthy, W., Hersey, P., et al.: Solar keratoses: A risk factor for melanoma but negative association with melanocytic naevi. Int. J. Cancer 78, 8-12 (1998)
110. Whiteman, D.C., Green, A., Parson, P.G.: p53 Expression and risk factors for cutaneous melanoma: a case-control study. Int. J. Cancer 77, 843-848 (1998)
111. Urso, C., Giannotti, V., Reali, U.M., Giannotti, B., Bondi, R.: Spatial association of melanocytic naevus and melanoma. Melanoma Res. 1(4), 245-249 (1991)
112. Marks, R., Dorevitch, A.P., Mason, G.: Do all melanomas come from "moles"? A study of the histological association between melanocytic naevi and melanoma. Australas. J. Dermatol. 31(2), 77-80 (1990)
113. Kaddu, S., Smolle, J., Zenahlik, P., Hofmann-Wellenhof, R., Kerl, H.: Melanoma with benign melanocytic naevus components: reappraisal of clinicopathological features and prognosis. Melanoma Res. 12(3), 271-278 (2002)
114. Carli, P., Massi, D., Santucci, M., Biggeri, A., Gianotti, B.: Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: results from a case-control study. J. Am. Acad. Dermatol. 40, 549-557 (1999)
115. Carli, P., Massi, D., Santucci, M., Biggeri, A., Giannotti, B.: Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: results from a case-control study. J. Am. Acad. Dermatol. 40(4), 549-557 (1999)
116. Skender-Kalnenas, T.M., English, D.R., Heenan, P.J.: Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? J. Am. Acad. Dermatol. 33, 1000-1007 (1995)
117. Green, A.: A theory of site distribution of melanomas: Queensland, Australia. Cancer Causes Control 3, 513-516 (1992)
118. Purdue, M.P., From, L., Armstrong, B.K., Kricker, A., Gallagher, R.P., McLaughlin, J.R., et al.: Etiologic and other factors predicting nevus-Associated cutaneous malignant melanoma. Cancer Epidemiol. Biomarkers Prev. 14(8), 2015-2022 (2005)
119. Winnepenninckx, V., van den Oord, J.J.: p16INK4A expression in malignant melanomas with or without a contiguous naevus remnant: a clue to their divergent pathogenesis? Melanoma Res. 14, 321-322 (2004)
120. Autier, P., Dore, J.F., Cattaruzza, M.S., Renard, F., Luther, H., Gentiloni-Silverj, F., et al.: Sunscreen use, wearing clothes, and number of nevi in 6-To 7-year-old European children. J. Natl. Cancer Inst. 90, 1873-1880 (1998)
121. Gallagher, R.P., McLean, D.I., Yang, C.P., et al.: Suntan, sunburn and pigmentation factors and the frequency of acquired melanocytic nevi in children. Arch. Dermatol. 126, 770-776 (1990)
122. Wiecker, T.S., Luther, H., Buettner, P., Bauer, J., Garbe, C.: Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood: a risk factor study in 1,812 kindergarten children. Cancer 97(3), 628-638 (2003)
123. Wachsmuth, R.C., Turner, F., Barrett, J.H., Gaut, R., Randerson-Moor, J.A., Bishop, D.T., et al.: The effect of sun exposure in determining nevus density in UK adolescent twins. J. Invest. Dermatol. 124(1), 56-62 (2005)
124. Green, A., Sorohan, T., Pope, D., et al.: Moles in Australian and British schoolchildren. Lancet 2, 1497 (1988)
125. English, D.R., Armstrong, B.K.: Melanocytic nevi in children. I. Anatomic sites and demographic and host factors. Am. J. Epidemiol. 139, 390-401 (1994)
126. Harrison, S.L., MacLennan, R., Speare, R., Wronski, I.: Sun exposure and melanocytic naevi in young Australian children. Lancet 344, 1529-1532 (1994)
127. Whiteman, D.C., Brown, R.M., Purdie, D.M., Hughes, M.C.: Melanocytic nevi in very young children: the role of phenotype, sun exposure, and sun protection. J. Am. Acad. Dermatol. 52(1), 40-47 (2005)
128. Fritschi, L., McHenry, P., Green, A., MacKie, R., Green, L., Siskind, V.: Naevi in schoolchildren in Scotland and Australia. Br. J. Dermatol. 130, 599-603 (1994)
129. Kelly, J.W., Rivers, J.K., MacLennan, R., Harrison, S., Lewis, A.E., Tate, B.J.: Sunlight: A major factor associated with the development of melanocytic nevi in Australian schoolchildren. J. Am. Acad. Dermatol. 30, 40-48 (1994)
130. Zhu, G., Duffy, D.L., Eldridge, A., Grace, M., Mayne, C., O'Gorman, L., et al.: A major quantitative-Trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. Am. J. Hum. Genet. 65(2), 483-492 (1999)
131. Wachsmuth, R.C., Gaut, R.M., Barrett, J.H., Saunders, C.L., Randerson-Moor, J.A., Eldridge, A., et al.: Heritability and geneenvironment interactions for melanocytic nevus density examined in a U.K. adolescent twin study. J. Invest. Dermatol. 117(2), 348-352 (2001)
132. Whiteman, D.C., Watt, P., Purdie, D.M., Hughes, M.C., Hayward, N.K., Green, A.C.: Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J. Natl. Cancer Inst. 95(11), 806-812 (2003)
133. Bulliard, J.L., De Weck, D., Fisch, T., Bordoni, A., Levi, F.: Detailed site distribution of melanoma and sunlight exposure: aetiological patterns from a Swiss series. Ann. Oncol. 18(4), 789-794 (2007)
134. Cho, E., Rosner, B.A., Colditz, G.A.: Risk factors for melanoma by body site. Cancer Epidemiol. Biomarkers Prev. 14(5), 1241-1244 (2005)
135. Naldi, L., Altieri, A., Imberti, G.L., Gallus, S., Bosetti, C., La Vecchia, C.: Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma. An analysis according to different clinico-pathological variants and anatomic locations (Italy). Cancer Causes Control 16(8), 893-899 (2005)
136. Randi, G., Naldi, L., Gallus, S., Di Landro, A., La Vecchia, C.: Number of nevi at a specific anatomical site and its relation to cutaneous malignant melanoma. J. Invest. Dermatol. 126(9), 2106-2110 (2006)
137. Thomas, N.E.: BRAF somatic mutations in malignant melanoma and melanocytic naevi. Melanoma Res. 16(2), 97-103 (2006)
138. Lang, J., MacKie, R.M.: Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral, and lentigo maligna subtypes. J. Invest. Dermatol. 125(3), 575-579 (2005)
139. Thomas, N.E., Edmiston, S.N., Alexander, A., Millikan, R.C., Groben, P.A., Hao, H., et al.: Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma. Cancer Epidemiol. Biomarkers Prev. 16(5), 991-997 (2007)
140. Liu, W., Kelly, J.W., Trivett, M., Murray, W.K., Dowling, J.P., Wolfe, R., et al.: Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma. J. Invest. Dermatol. 127(4), 900-905 (2007)
141. Poynter, J.N., Elder, J.T., Fullen, D.R., Nair, R.P., Soengas, M.S., Johnson, T.M., et al.: BRAF and NRAS mutations in melanoma and melanocytic nevi. Melanoma Res. 16(4), 267-273 (2006)
142. Edlundh-Rose, E., Egyhazi, S., Omholt, K., Mansson-Brahme, E., Platz, A., Hansson, J., et al.: NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing. Melanoma Res. 16(6), 471-478 (2006)
143. Bauer, J., Curtin, J.A., Pinkel, D., Bastian, B.C.: Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations. J. Invest. Dermatol. 127(1), 179-182 (2007)
144. Landi, M.T., Bauer, J., Pfeiffer, R.M., Elder, D.E., Hulley, B., Minghetti, P., et al.: MC1R germline variants confer risk for BRAF-mutant melanoma. Science 313(5786), 521-522 (2006)